Amyloidosis

• Study evaluating the Safety and Efficacy of Etentamig (ABBV-383) in Subjects with Light Chain Amyloidosis Recruitment ended
  2023-503429-20-00 8 2024-07-31 "Light Chain Amyloidosis"
• A Study to Establish the Bioequivalence of Free Acid Tafamidis 61 mg Capsule and Tablet, and Evaluate the Safety and Tolerability of the 61 … Ended
  2026-525342-29-00 2 2026-03-16 "Transthyretin amyloidosis"
• A study to establish the bioequivalence of free acid tafamidis 61 mg capsule and tablet, and evaluate the safety and tolerability of the 61 … Ended
  2024-514166-40-00 2 2024-12-16 "Transthyretin amyloidosis"
• A study to learn how different forms of study medicine tafamidis are taken up into the blood in healthy adults Ended
  2023-509241-12-00 3 2024-02-15 "aransthyretin amyloid cardiomyopathy"
• Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis Ended
  2024-513075-40-00 4 2021-03-01 "Relapsed or refractory AL amyloidosis"
• IFM 2020-01 (Isamyp) Efficacity assessment of isatuximab plus pomalidomide and dexamethasone in patients with AL amyloidosis who didn't reac … Ended
  2024-513887-25-00 4 "AL Amyloidosis"

Showing 1–6 of 6 trials